Alnylam Pharmaceuticals (NASDAQ:ALNY) Shares Gap Up on Analyst Upgrade
Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) gapped up prior to trading on Friday after Citigroup raised their price target on the stock from $338.00 to $351.00. The stock had previously closed at $253.55, but opened at $261.82. Citigroup currently has a buy rating on the stock. Alnylam Pharmaceuticals shares last traded […]
Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) gapped up prior to trading on Friday after Citigroup raised their price target on the stock from $338.00 to $351.00. The stock had previously closed at $253.55, but opened at $261.82. Citigroup currently has a buy rating on the stock. Alnylam Pharmaceuticals shares last traded […]
